Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer

Detalhes bibliográficos
Autor(a) principal: Lima, Emanuelle do Nascimento Santos
Data de Publicação: 2021
Outros Autores: Ferreira, Isabela Borges, Silva, Nayara Cristina da, Prestes, Isaías Valente, Pena, Geórgia das Graças
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/1209
Resumo: Introduction: Cancer is one of the leading causes of morbidity and mortality worldwide. There are few studies showing adjusted models with other predictors of mortality by a conceptual model perspective. Objective: The objective of this study was to verify the prediction of albumin and Prognostic Nutritional Index (PNI) with in-hospital mortality in cancer patients. Method: Retrospective study was performed from 2014 to 2016 with 262 cancer patients (gastrointestinal tract, male genital organs, breast, metastasis, urinary tract, head and neck and others). Demographic data, blood counts, C-reactive protein, albumin, and haematological indexes (Prognosis nutritional index - PNI, Neutrophils to lymphocytes ratio - NLR, Monocytes lymphocytes ratio - MLR, Platelets to lymphocytes ratio - PLR and Platelets to albumin ratio - PAR), nutritional diagnoses and hospital outcomes (discharge or death) were collected. The cumulative probability of death was calculated by Kaplan-Meier curves, and survival analyses were performed using the Cox proportional hazards model. Results: The frequency of death among the study patients was 10.7% (28). Among the patients who died, 99.2% (26) presented some degree of malnutrition (p=0.004). In the multivariate analysis, serum albumin (<3 g/dL) was independently associated with in-hospital mortality (HR=3.43, 95% CI 1.11-10.63). On the other hand, the PNI was not associated with in-hospital mortality. Conclusion: Serum albumin levels during hospitalization were predictors of in-hospital mortality in the population evaluated. These results suggest that the serum levels of this protein can be used in clinical practice, adding prognostic information in patients with cancer.
id INCA-1_1f9422896f23e6e55b269e8107ba9992
oai_identifier_str oai:rbc.inca.gov.br:article/1209
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Serum Albumin is Independent Predictor of Hospital Mortality in Patients with CancerLa Albúmina Sérica es un Predictor Independiente de Mortalidad Hospitalaria en Pacientes con CáncerA Albumina Sérica é Preditor Independente de Mortalidade Hospitalar em Pacientes com CâncerAlbumina SéricaMortalidade HospitalarAvaliação NutricionalNeoplasiasPrognósticoSerum AlbuminHospital MortalityNutritional AssessmentNeoplasmsPrognosisAlbúmina SéricaMortalidad HospitalariaEvaluación NutricionalNeoplasiasPrognósticoIntroduction: Cancer is one of the leading causes of morbidity and mortality worldwide. There are few studies showing adjusted models with other predictors of mortality by a conceptual model perspective. Objective: The objective of this study was to verify the prediction of albumin and Prognostic Nutritional Index (PNI) with in-hospital mortality in cancer patients. Method: Retrospective study was performed from 2014 to 2016 with 262 cancer patients (gastrointestinal tract, male genital organs, breast, metastasis, urinary tract, head and neck and others). Demographic data, blood counts, C-reactive protein, albumin, and haematological indexes (Prognosis nutritional index - PNI, Neutrophils to lymphocytes ratio - NLR, Monocytes lymphocytes ratio - MLR, Platelets to lymphocytes ratio - PLR and Platelets to albumin ratio - PAR), nutritional diagnoses and hospital outcomes (discharge or death) were collected. The cumulative probability of death was calculated by Kaplan-Meier curves, and survival analyses were performed using the Cox proportional hazards model. Results: The frequency of death among the study patients was 10.7% (28). Among the patients who died, 99.2% (26) presented some degree of malnutrition (p=0.004). In the multivariate analysis, serum albumin (<3 g/dL) was independently associated with in-hospital mortality (HR=3.43, 95% CI 1.11-10.63). On the other hand, the PNI was not associated with in-hospital mortality. Conclusion: Serum albumin levels during hospitalization were predictors of in-hospital mortality in the population evaluated. These results suggest that the serum levels of this protein can be used in clinical practice, adding prognostic information in patients with cancer.Introducción: El cáncer es una de las principales causas de morbilidad y mortalidad en todo el mundo. Hay pocos estudios que muestren modelos ajustados con otros predictores de mortalidad desde una perspectiva de modelo conceptual. Objetivo: El objetivo de este estudio fue verificar la predicción de la albumina y el Índice Nutricional Pronostico (IPN) con la mortalidad hospitalaria en pacientes con cáncer (tracto gastrointestinal, órganos genitales masculinos, mama, metástasis, tracto urinario, cabeza y cuello y otros). Método: Se realizo un estudio retrospectivo de 2014 a 2016 con 262 pacientes con cáncer. Se recogieron datos demográficos, hemogramas, proteína C reactiva, albumina y índices hematológicos (Índice de Pronostico Nutricional - IPN, proporción neutrófilos/linfocitos - NLR, proporción monocitos/linfocitos - MLR, proporción plaquetas/linfocitos - PLR y proporción plaquetas/albumina - PAR), diagnósticos nutricionales y resultados hospitalarios (alta o muerte). La probabilidad acumulada de muerte se calculó mediante curvas de Kaplan-Meier y se realizaron análisis supervivencia utilizando el modelo de riesgos proporcionales de Cox. Resultados: La frecuencia de muerte entre los pacientes del estudio fue del 10,7% (28). Entre los pacientes fallecidos, el 99,2% (26) presentaba algún grado de desnutrición (p=0,004). En el análisis multivariado, la albumina sérica (<3 g/dL) se asoció de forma independiente con la mortalidad hospitalaria (HR=3,43, IC 95% 1,11-10,63). Por otro lado, el IPN no se asoció con mortalidad intrahospitalaria. Conclusión: Los niveles de albumina sérica durante la hospitalización fueron predictores de mortalidad intrahospitalaria en la población evaluada. Nuestros resultados sugieren que los niveles séricos de esta proteína se pueden utilizar en la práctica clínica, agregando información de pronóstico en pacientes con cáncer.Introdução: O câncer e uma das principais causas de morbidade e mortalidade em todo o mundo. Existem poucos estudos mostrando modelos ajustados com outros preditores de mortalidade por uma perspectiva de modelo conceitual. Objetivo: Verificar a predição de albumina e do Índice Nutricional Prognostico (IPN) com mortalidade intra-hospitalar em pacientes com câncer. Método: Estudo retrospectivo realizado de 2014 a 2016 com 262 pacientes com câncer (trato gastrointestinal, órgãos genitais masculinos, mama, metástases, trato urinário, cabeça e pescoço e outros). Foram coletados dados demográficos, hemograma, proteína C reativa, albumina e índices hematológicos (índice de prognostico nutricional - IPN; relação neutrófilo por linfócitos - RNL; relação monócitos por linfócitos - RML; relação plaquetas por linfócitos - RPL; e relação plaquetas por albumina – RPA), diagnósticos nutricionais e desfechos hospitalares (alta ou óbito). A probabilidade cumulativa de morte foi calculada pelas curvas de Kaplan-Meier e as análises de sobrevivência realizadas usando o modelo de risco proporcional de Cox. Resultados: A frequência de óbito entre os pacientes do estudo foi de 10,7% (28). Entre os pacientes que morreram, 99,2% (26) apresentavam algum grau de desnutrição (p=0,004). Na análise multivariada, a albumina sérica (<3 g/dL) associou-se de forma independente a mortalidade hospitalar (HR=3,43, IC95% 1,11-10,63). Por outro lado, o IPN não foi associado com mortalidade intra-hospitalar. Conclusão: Os níveis de albumina sérica durante a internação foram preditores de mortalidade intra-hospitalar na população avaliada. Esses resultados sugerem que os níveis séricos dessa proteína podem ser utilizados na prática clínica, agregando informações prognosticas em pacientes com câncer.INCA2021-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/120910.32635/2176-9745.RBC.2021v67n4.1209Revista Brasileira de Cancerologia; Vol. 67 No. 4 (2021): Oct./Nov./Dec.; e-071209Revista Brasileira de Cancerologia; Vol. 67 Núm. 4 (2021): oct./nov./dic.; e-071209Revista Brasileira de Cancerologia; v. 67 n. 4 (2021): out./nov./dez.; e-0712092176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAenghttps://rbc.inca.gov.br/index.php/revista/article/view/1209/1521Copyright (c) 2021 Revista Brasileira de Cancerologiahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLima, Emanuelle do Nascimento Santos Ferreira, Isabela Borges Silva, Nayara Cristina da Prestes, Isaías Valente Pena, Geórgia das Graças2022-10-14T18:57:34Zoai:rbc.inca.gov.br:article/1209Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2022-10-14T18:57:34Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
La Albúmina Sérica es un Predictor Independiente de Mortalidad Hospitalaria en Pacientes con Cáncer
A Albumina Sérica é Preditor Independente de Mortalidade Hospitalar em Pacientes com Câncer
title Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
spellingShingle Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
Lima, Emanuelle do Nascimento Santos
Albumina Sérica
Mortalidade Hospitalar
Avaliação Nutricional
Neoplasias
Prognóstico
Serum Albumin
Hospital Mortality
Nutritional Assessment
Neoplasms
Prognosis
Albúmina Sérica
Mortalidad Hospitalaria
Evaluación Nutricional
Neoplasias
Prognóstico
title_short Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
title_full Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
title_fullStr Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
title_full_unstemmed Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
title_sort Serum Albumin is Independent Predictor of Hospital Mortality in Patients with Cancer
author Lima, Emanuelle do Nascimento Santos
author_facet Lima, Emanuelle do Nascimento Santos
Ferreira, Isabela Borges
Silva, Nayara Cristina da
Prestes, Isaías Valente
Pena, Geórgia das Graças
author_role author
author2 Ferreira, Isabela Borges
Silva, Nayara Cristina da
Prestes, Isaías Valente
Pena, Geórgia das Graças
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Lima, Emanuelle do Nascimento Santos
Ferreira, Isabela Borges
Silva, Nayara Cristina da
Prestes, Isaías Valente
Pena, Geórgia das Graças
dc.subject.por.fl_str_mv Albumina Sérica
Mortalidade Hospitalar
Avaliação Nutricional
Neoplasias
Prognóstico
Serum Albumin
Hospital Mortality
Nutritional Assessment
Neoplasms
Prognosis
Albúmina Sérica
Mortalidad Hospitalaria
Evaluación Nutricional
Neoplasias
Prognóstico
topic Albumina Sérica
Mortalidade Hospitalar
Avaliação Nutricional
Neoplasias
Prognóstico
Serum Albumin
Hospital Mortality
Nutritional Assessment
Neoplasms
Prognosis
Albúmina Sérica
Mortalidad Hospitalaria
Evaluación Nutricional
Neoplasias
Prognóstico
description Introduction: Cancer is one of the leading causes of morbidity and mortality worldwide. There are few studies showing adjusted models with other predictors of mortality by a conceptual model perspective. Objective: The objective of this study was to verify the prediction of albumin and Prognostic Nutritional Index (PNI) with in-hospital mortality in cancer patients. Method: Retrospective study was performed from 2014 to 2016 with 262 cancer patients (gastrointestinal tract, male genital organs, breast, metastasis, urinary tract, head and neck and others). Demographic data, blood counts, C-reactive protein, albumin, and haematological indexes (Prognosis nutritional index - PNI, Neutrophils to lymphocytes ratio - NLR, Monocytes lymphocytes ratio - MLR, Platelets to lymphocytes ratio - PLR and Platelets to albumin ratio - PAR), nutritional diagnoses and hospital outcomes (discharge or death) were collected. The cumulative probability of death was calculated by Kaplan-Meier curves, and survival analyses were performed using the Cox proportional hazards model. Results: The frequency of death among the study patients was 10.7% (28). Among the patients who died, 99.2% (26) presented some degree of malnutrition (p=0.004). In the multivariate analysis, serum albumin (<3 g/dL) was independently associated with in-hospital mortality (HR=3.43, 95% CI 1.11-10.63). On the other hand, the PNI was not associated with in-hospital mortality. Conclusion: Serum albumin levels during hospitalization were predictors of in-hospital mortality in the population evaluated. These results suggest that the serum levels of this protein can be used in clinical practice, adding prognostic information in patients with cancer.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1209
10.32635/2176-9745.RBC.2021v67n4.1209
url https://rbc.inca.gov.br/index.php/revista/article/view/1209
identifier_str_mv 10.32635/2176-9745.RBC.2021v67n4.1209
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/1209/1521
dc.rights.driver.fl_str_mv Copyright (c) 2021 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2021 Revista Brasileira de Cancerologia
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 67 No. 4 (2021): Oct./Nov./Dec.; e-071209
Revista Brasileira de Cancerologia; Vol. 67 Núm. 4 (2021): oct./nov./dic.; e-071209
Revista Brasileira de Cancerologia; v. 67 n. 4 (2021): out./nov./dez.; e-071209
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042246200066048